Martínez-Puente Maria del Carmen, Pascual-Montero José Antonio, García-Olmo Damián
Instituto Coloproctológico, C/General Ibáñez Ibero 5B, 28003 Madrid, Spain.
Int J Colorectal Dis. 2004 May;19(3):210-4. doi: 10.1007/s00384-003-0537-5. Epub 2003 Oct 7.
Biofeedback therapy has been extensively used and accepted in fecal incontinence, but reports of its efficiency vary. We evaluated feedback therapy efficiency when (a) selecting the patient's subject of the therapy, and (b) customizing the therapy protocol used for each patient.
Fifty-three patients with fecal incontinence were selected for biofeedback training. The treatment program was customized for each patient depending on the underlying dysfunction, the patient's cooperative and learning attitude, and the patient's progress. Biofeedback efficiency was measured using clinical scores, subjective satisfaction of the patient, and manometry.
Incontinent scores showed improvement in 66% of patients and good improvement in 11% and 15%, respectively, indicating an overall excellent effect of the therapy. Subjective satisfaction was strongly correlated with the previous incontinent scores. Comparison of manometry parameters before and after biofeedback therapy, including maximum anal resting, maximum anal squeeze pressure, and maximum duration of the squeeze, all showed significant differences. In addition, the sensory threshold significantly decreased after biofeedback therapy. Clinical improvements were maintained during the following 12 months.
Biofeedback improves objective and subjective parameters of anorectal function. Selection of patients and customization of the therapy program increased biofeedback efficiency for the treatment of fecal incontinence.
生物反馈疗法已在大便失禁治疗中得到广泛应用并被接受,但关于其疗效的报道存在差异。我们评估了在(a)选择患者的治疗主题,以及(b)为每位患者定制治疗方案时生物反馈疗法的疗效。
选取53例大便失禁患者进行生物反馈训练。根据潜在功能障碍、患者的合作与学习态度以及患者的进展为每位患者定制治疗方案。使用临床评分、患者主观满意度和测压法来衡量生物反馈疗效。
失禁评分显示66%的患者有所改善,分别有11%和15%的患者有明显改善,表明该疗法总体效果极佳。主观满意度与之前的失禁评分密切相关。生物反馈治疗前后测压参数的比较,包括最大肛门静息压、最大肛门收缩压和最大收缩持续时间,均显示出显著差异。此外,生物反馈治疗后感觉阈值显著降低。临床改善在接下来的12个月内得以维持。
生物反馈改善了肛肠功能的客观和主观参数。患者的选择和治疗方案的定制提高了生物反馈治疗大便失禁的疗效。